The spectrum of thrombotic complications associated with Ozempic includes these serious conditions: Deep vein thrombosis manifesting as leg swelling, pain, warmth, and redness Pulmonary embolism causing sudden shortness of breath, chest pain, and potential cardiac arrest Post-thrombotic syndrome resulting in chronic leg pain, swelling, and skin changes Venous thromboembolism requiring long-term anticoagulation therapy Increased surgical risks for patients needing procedures while on Ozempic Potential stroke risk from paradoxical embolism in patients with patent foramen ovale Economic burden of lifelong anticoagulation monitoring and management The 266% increased risk identified in peer-reviewed research represents a massive elevation in thrombotic risk that should have triggered immediate regulatory action and prominent warnings

These issues now form the foundation of coordinated legal actions involving Trulicity and other GLP-1 medications: Trulicity is included because it belongs to the same GLP-1 drug class as other medications under scrutiny, and lawsuits claim that class-wide effects on gut motility may be relevant to the injuries alleged
(trimrx.com) Color Changes Any shift away from water-clear is a red flag
Administration method Administration Method - Sourced: Aesthetica Montgomery The oral formulation of semaglutide is in the form of tablets or capsules, which patients can take directly and are easy to carry and use
For one, the medication can alter metabolic processes and energy utilization, leading to feelings of exhaustion